“There’s not a magical thing where you give them the infusion and they wake up and they’re better,” she said. “It’s going to take time. There are obviously a lot of other factors. Once we have results of the entire trial, with thousands of patients, we’ll be able to see whether the plasma had any impact on the general population or not.”